Curia is a global contract research, development, and manufacturing organisation (CDMO) that partners with pharmaceutical and biotechnology companies to transform ideas into real-world impact.

Founded in 1991 as Albany Molecular Research, Inc. (AMRI), Curia has evolved over three decades to offer a comprehensive suite of solutions across the drug development spectrum. With deep scientific expertise and a robust global network, Curia provides flexible and scalable services to accelerate the delivery of products to patients.

Key products and services include:

• Small Molecules: Offering strategic solutions for early drug discovery services, compound development, and manufacturing.
• Generic Active Pharmaceutical Ingredients (APIs): Providing the capacity to meet clientsr complex products on time.
• Biologics: Delivering comprehensive capabilities from discovery to Good Manufacturing Practuring.
• Sterile Fill-Finish: Specialising in clinical and commercial sterile manufacturing.
• Analytical Services: Offering a complete range of analytical solutions to support discovmercialisation.

With over 30 years of experience, Curia remains a dedicated ally to its clients, navigating thdrug discovery, development, and manufacturing with unwavering commitment and collaboration at its core.